Mitostatin and Prostate Cancer
Author Information
Author(s): Fassan Matteo, D'Arca Domenico, Letko Juraj, Vecchione Andrea, Gardiman Marina P., McCue Peter, Wildemore Bernadette, Rugge Massimo, Shupp-Byrne Dolores, Gomella Leonard G., Morrione Andrea, Iozzo Renato V., Baffa Raffaele
Primary Institution: Kimmel Cancer Center, Thomas Jefferson University
Hypothesis
Mitostatin acts as a tumor suppressor gene in prostate cancer.
Conclusion
Mitostatin may play a significant role as a tumor suppressor in prostate cancer development and progression.
Supporting Evidence
- Mitostatin was absent in approximately 35% of prostate tumor samples.
- Mitostatin over-expression inhibited cell growth and migration in prostate cancer cells.
- Mitostatin expression was significantly down-regulated in cancerous tissues compared to normal tissues.
Takeaway
Mitostatin is a protein that helps stop prostate cancer cells from growing and spreading. When there's less of it, the cancer can get worse.
Methodology
The study involved over-expressing and depleting Mitostatin in prostate cancer cell lines and analyzing its effects on cell growth, migration, invasion, and tumorigenicity.
Limitations
The study did not find significant correlations between Mitostatin expression and other clinical parameters used to assess prostate cancer prognosis.
Participant Demographics
The study included 124 prostate cancer samples and matched normal tissues.
Statistical Information
P-Value
0.029
Statistical Significance
p=0.029
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website